10 insiders reported 56 Form 4 transactions for Monte Rosa Therapeutics, Inc. (GLUE) over the past 18 months (most recent 2026-07-07). Recent activity: Townson Sharon (Chief Scientific Officer) Buy 6,000 shares, Townson Sharon (Chief Scientific Officer) Sell 5,600 shares, Townson Sharon (Chief Scientific Officer) Sell 400 shares, Behbahani Ali (Director) Sell 1.0M shares, Behbahani Ali (Director) Buy 15,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | Townson Sharon | Chief Scientific Officer | Buy | 6,000 | $36,840 |
| 2026-07-07 | Townson Sharon | Chief Scientific Officer | Sell | 5,600 | $130,197 |
| 2026-07-07 | Townson Sharon | Chief Scientific Officer | Sell | 400 | $9,652 |
| 2026-07-06 | Behbahani Ali | Director | Sell | 1.0M | $0 |
| 2026-07-06 | Behbahani Ali | Director | Buy | 15,000 | $0 |
| 2026-07-06 | Behbahani Ali | Director | Sell | 15,000 | $0 |
| 2026-07-01 | Janku Filip | Chief Medical Officer | Buy | 5,407 | $72,508 |
| 2026-07-01 | Janku Filip | Chief Medical Officer | Sell | 5,407 | $132,472 |
| 2026-06-30 | Manning Anthony M. | Director | Buy | 10,000 | $41,600 |
| 2026-06-30 | Janku Filip | Chief Medical Officer | Buy | 6,000 | $45,360 |
| 2026-06-30 | Janku Filip | Chief Medical Officer | Sell | 6,000 | $137,700 |
| 2026-06-30 | Manning Anthony M. | Director | Sell | 10,000 | $231,100 |
| 2026-06-25 | Townson Sharon | Chief Scientific Officer | Buy | 3,000 | $18,420 |
| 2026-06-25 | Janku Filip | Chief Medical Officer | Buy | 6,000 | $45,360 |
| 2026-06-25 | Champoux Jennifer | Chief Operating Officer | Buy | 2,175 | $8,656 |
| 2026-06-25 | Townson Sharon | Chief Scientific Officer | Sell | 3,000 | $60,000 |
| 2026-06-25 | Janku Filip | Chief Medical Officer | Sell | 11,845 | $239,522 |
| 2026-06-25 | Champoux Jennifer | Chief Operating Officer | Sell | 2,175 | $43,500 |
| 2026-06-25 | Janku Filip | Chief Medical Officer | Buy | 30,000 | $226,800 |
| 2026-06-25 | Janku Filip | Chief Medical Officer | Sell | 30,000 | $642,681 |
| 2026-06-18 | Townson Sharon | Chief Scientific Officer | Buy | 3,000 | $18,420 |
| 2026-06-18 | Champoux Jennifer | Chief Operating Officer | Buy | 2,176 | $8,660 |
| 2026-06-18 | Townson Sharon | Chief Scientific Officer | Sell | 3,000 | $57,000 |
| 2026-06-18 | Champoux Jennifer | Chief Operating Officer | Sell | 2,176 | $41,344 |
| 2026-06-02 | Warmuth Markus | President & CEO | Sell | 4,998 | $97,021 |
Source: SEC Form 4 filings · as of 2026-07-07